Search - tctmd.com

Displaying 1 - 20 of 39

Sort: Relevancy | Date

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Industry News

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

September 12, 2019

News Industry News

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

July 16, 2019

News Industry News

Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform

July 15, 2019

News Industry News

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

July 01, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Industry News

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

April 26, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

News Industry News

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

March 14, 2019

News Industry News

HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair

April 19, 2018

News Industry News

Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

January 24, 2018

News Industry News

4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec

July 20, 2017

News Industry News

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

June 16, 2017

News Industry News

4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

June 08, 2017

News Industry News

LivaNova Acquires Caisson Interventional, LLC

May 02, 2017

News Industry News

Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation

December 01, 2016

News Industry News

Mitralign Completes Enrollment in First Phase of US Early Feasibility Study on Tricuspid Repair

July 13, 2016

News Industry News

Valcare Medical, an Accelmed Portfolio Company, Announces Successful First-In-Human Procedures of the Amend™ Catheter Delivered Annuloplasty Ring

June 20, 2016

News Industry News

NeoChord Receives FDA Approval to begin Clinical Trial for Treatment of Degenerative Mitral Valve Regurgitation

May 16, 2016

Advertisement

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair

Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

LivaNova Acquires Caisson Interventional, LLC

Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation

Mitralign Completes Enrollment in First Phase of US Early Feasibility Study on Tricuspid Repair

Valcare Medical, an Accelmed Portfolio Company, Announces Successful First-In-Human Procedures of the Amend™ Catheter Delivered Annuloplasty Ring

NeoChord Receives FDA Approval to begin Clinical Trial for Treatment of Degenerative Mitral Valve Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content